SPONSOR
OHB Pediatrics Ltd.
Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Angelman Syndrome
OHB Pediatrics Ltd. is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Angelman Syndrome.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — OHB Pediatrics Ltd.
How many clinical trials has OHB Pediatrics Ltd. sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by OHB Pediatrics Ltd., of which 1 are actively recruiting participants. These trials cover conditions including Angelman Syndrome. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does OHB Pediatrics Ltd. research focus on?
OHB Pediatrics Ltd. clinical trials span Angelman Syndrome. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a OHB Pediatrics Ltd. clinical trial?
To participate in a OHB Pediatrics Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all OHB Pediatrics Ltd. trials with current recruitment status updated daily.
Clinical Trials by OHB Pediatrics Ltd.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology